2019年1月14日，歐盟食品安全局（EFSA）發(fā)布消息，擬制定螺甲螨酯（spiromesifen）在咖啡豆中的進(jìn)口限量。

　　根據(jù)法規(guī)（EC）No 396/2005第6條，Bayer CropScience向希臘國家主管部門提交申請(qǐng)，要求制定螺甲螨酯在咖啡豆中的進(jìn)口限量。申請(qǐng)之后轉(zhuǎn)至歐盟食品安全局。經(jīng)過評(píng)估，歐盟食品安全局得出結(jié)論，根據(jù)所報(bào)道的農(nóng)業(yè)實(shí)踐，短期和長期攝入使用螺甲螨酯而產(chǎn)生的殘留物不太可能對(duì)消費(fèi)者健康構(gòu)成風(fēng)險(xiǎn)。

　　部分原文報(bào)道如下：

　　In accordance with Article 6 of Regulation （EC） No 396/2005, the applicant Bayer CropScience submitted a request to the competent national authority in Greece to set an import tolerance for the active substance spiromesifen in coffee beans. The data submitted in support of the request were found to be sufficient to derive a maximum residue level （MRL） proposal for coffee beans. Adequate analytical methods for enforcement are available to control the residues of spiromesifen and spiromesifen‐enol （M01） on the commodity under consideration at the validated limit of quantification （LOQ） of 0.01 mg/kg for each compound. based on the risk assessment results, EFSA concluded that the short‐term and long‐term intake of residues resulting from the use of spiromesifen according to the reported agricultural practices is unlikely to present a risk to consumer health.